(Q70646189)
Statements
Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans (English)
Rowinsky EK
Noe DA
Ettinger DS
Christian MC
Lubejko BG
Sartorius SE
Boyd MR